| 钟颖雨,张颖婕,王 贺,等.2018—2022年深圳市宫颈癌早诊早治情况分析[J].中国肿瘤,2024,33(12):1027-1032. |
| 2018—2022年深圳市宫颈癌早诊早治情况分析 |
| Analysis of Cervical Cancer Early Diagnosis and Treatment in Shenzhen from 2018 to 2022 |
| 投稿时间：2023-12-20 |
| DOI：10.11735/j.issn.1004-0242.2024.12.A010 |
|
 |
| 中文关键词: 宫颈癌 筛查 早诊早治 HPV疫苗 广东 |
| 英文关键词:cervical cancer screening early diagnosis and treatment HPV vaccine Guangdong |
| 基金项目:中国癌症基金会资助项目（INV-031449） |
|
| 摘要点击次数: 195 |
| 全文下载次数: 44 |
| 中文摘要: |
| 摘 要：［目的］ 分析深圳市女性2018—2022年宫颈癌筛查与早诊早治的基本情况。［方法］ 对2018年1月至2022年12月深圳市妇幼保健系统宫颈癌防治信息平台收集到的2 419 037人次宫颈癌筛查数据资料进行回顾性分析，统计和计算筛查数量、病变检出率、早诊率、治疗率等指标。［结果］ 2018—2022年期间参加筛查的人数逐年上升。筛查人群中机会性筛查占32.71%，政府计划筛查占53.72%，健康体检筛查占15.83%。CIN2及以上病变总人数为5 392人，CIN2+CIN3或原位癌+早期癌总人数为5 235人，实际治疗总人数4 996人，治疗失访总人数396人。CIN2及以上病变检出率平均为0.23%，早诊率平均为96.92%，治疗率在2021—2022年达到95%。［结论］ 自2017年我国开始接种HPV疫苗以来，深圳市参加宫颈癌筛查的人群数量逐年上升，其中政府计划筛查人数占大多数；早诊率、治疗率在2020年后均达到较高水平。 |
| 英文摘要: |
| Abstract： ［Purpose］ To analyze the fundamental data of cervical cancer screening， early diagnosis， and treatment in Shenzhen from 2018 to 2022. ［Methods］ A retrospective analysis was conducted on data obtained from the Shenzhen Maternal and Child Health System’s cervical cancer prevention and treatment information platform between January 2018 and December 2022， encompassing a total of 2 419 037. Number of screening， detection rate， early diagnosis rate and treatment rate were calculated. ［Results］ The participation rate in the screening program exhibited a consistent annual increased from 2018 to 2022. Amongst the screened population， opportunistic screening accounted for 32.71%， government planned screening constituted 53.72%， while physical examination-based screenings represented 15.83%. Notably， there were a total of 5 392 women diagnosed with CIN2 or above lesions； among them， there were also a total of 5 235 women diagnosed with CIN2+CIN3/carcinoma in situ+early-stage cancer. Furthermore， out of these cases identified through screening programs， a total of 4 996 women received appropriate treatment while only a small number (396) were lost to follow-up. The average detection rate for CIN2 and above lesions was found to be at an encouraging level of approximately 0.23%， with an impressive average early diagnosis rate reaching as high as 96.92%. Moreover， it was projected that from 2021 to 2022 the treatment rate exceeded 95%. ［Conclusion］ Since the start of HPV vaccination in China in 2017， the number of people participating in cervical cancer screening in Shenzhen has increased year by year， with the majority of government planned screening population. The early diagnosis rate and treatment rate have reached high levels after 2020. |
|
在线阅读
查看全文 查看/发表评论 下载PDF阅读器 |